The landscape of patients with metastatic breast cancer enrolled in phase I trials

被引：0
|
作者：
Marra [1 ]
Criscitiello, C. [2 ]
Morganti, S. [1 ]
Zagami, P. [1 ]
Viale, G. [1 ]
Tarantino, P. [1 ]
Trapani, D. [1 ]
Nicolo, E. [1 ]
Repetto, M. [1 ]
Ferraro, E. [1 ]
D'Amico, P. [1 ]
Locatelli, M. [2 ]
Esposito, A. [2 ]
Curigliano, G. [1 ]
机构：
[1] Univ Milan, European Inst Oncol IRCCS, Dept Oncol & Haematooncol, Div Early Drug Dev Innovat Therapies,IEO, Milan, Italy
[2] European Inst Oncol IRCCS, IEO, Div Early Drug Dev Innovat Therapies, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.03.251
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
151P
引用
收藏
页码：S70 / S71
页数：2
相关论文
共 50 条
  • [1] Clinical outcomes of patients with metastatic breast cancer enrolled in phase I clinical trials
    Criscitiello, Carmen
    Marra, Antonio
    Morganti, Stefania
    Zagami, Paola
    Gandini, Sara
    Esposito, Angela
    Curigliano, Giuseppe
    EUROPEAN JOURNAL OF CANCER, 2021, 157 : 40 - 49
  • [2] Patients with metastatic breast cancer enrolled in phase I clinical trials: Clinical outcomes and cohort trends.
    Weiss, Jennifer
    Gao, Dexiang
    Elias, Anthony D.
    Borges, Virginia F.
    Kabos, Peter
    Davis, S. Lindsey
    Leong, Stephen
    Diamond, Jennifer Robinson
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Profile and outcome of cancer patients enrolled in contemporary phase I trials
    Alouani, Emily
    Gazzah, Anas
    Mercier, Sandrine
    Bahleda, Ratislav
    Hollebecque, Antoine
    Michot, Jean-Marie
    Baldini, Capucine
    Ammari, Samy
    Champiat, Stephane
    Marabelle, Aurelien
    Postel-Vinay, Sophie
    Ribrag, Vincent
    Loriot, Yohann
    Aix, Santiago Ponce
    Mahjoubi, Linda
    EUROPEAN JOURNAL OF CANCER, 2023, 188 : 1 - 7
  • [4] Characterization and outcomes of patients enrolled to multiple phase I cancer trials
    Kuehne, Nathan
    Chen, Lina
    McDonald, Kate
    Wang, Lisa
    Spreafico, Anna
    Hansen, Aaron
    Razak, Albiruni Ryan Abdul
    Bedard, Philippe Lucien
    Siu, Lillian L.
    Shepshelovich, Daniel
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (02) : 469 - 472
  • [5] Characterization and outcomes of patients enrolled to multiple phase I cancer trials
    Nathan Kuehne
    Lina Chen
    Kate McDonald
    Lisa Wang
    Anna Spreafico
    Aaron Hansen
    Albiruni Ryan Abdul Razak
    Philippe Lucien Bedard
    Lillian L. Siu
    Daniel Shepshelovich
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 469 - 472
  • [6] Patients with metastatic prostate cancer enrolled in phase 1 trials: Outcomes and molecular alterations
    Bonnet, C.
    Alvarez, E. Castanon
    Michot, J-M.
    Bigot, F.
    Varga, A.
    Gazzah, A.
    Bahleda, R.
    Marabelle, A.
    Hollebecque, A.
    Aspeslagh, S.
    Angevin, E.
    Armand, J-P.
    Albiges, L.
    Loriot, Y.
    Postel-Vinay, S.
    Soria, J-C.
    Massard, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [7] Clinical outcome for patients with metastatic colorectal cancer (mCRC) enrolled in phase I clinical trials: Single institution experience
    Shah, Umang
    Pendurti, Gopichand
    Swami, Umang
    Hou, Yijuan
    Ghalib, Mohammad Haroon
    Chaudhary, Imran
    Mani, Sridhar
    Goel, Sanjay
    Aparo, Santiago
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Characteristics and outcome of breast cancer patients enrolled in cancer therapy evaluation program (CTEP) sponsored phase I clinical trials
    Lynce, Filipa
    Rubinstein, Larry
    Harris, Pamela
    CANCER RESEARCH, 2015, 75
  • [9] Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials
    Wells, J. Connor
    Sidhu, Aven
    Ding, Keyue
    Smoragiewicz, Martin
    Heng, Daniel Y. C.
    Shepherd, Frances A.
    Ellis, Peter M.
    Bradbury, Penelope A.
    Jonker, Derek J.
    Siu, Lillian L.
    Gelmon, Karen A.
    Karapetis, Christos
    Shapiro, Jeremy
    Nott, Louise
    O'Callaghan, Christopher J.
    Parulekar, Wendy R.
    Seymour, Lesley
    Monzon, Jose G.
    ONCOLOGIST, 2022, 27 (03): : E286 - E293
  • [10] Efficacy of immunotherapy agents in patients with metastatic breast cancer treated in phase I clinical trials.
    Kagihara, Jodi A.
    Weiss, Jennifer A.
    Nicklawsky, Andrew
    Gao, Dexiang
    Borges, Virginia F.
    Kabos, Peter
    Jimeno, Antonio
    Diamond, Jennifer R.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 69 - 70
12345